Ligand Funds AvenCell CAR T Pipeline
Ligand committed up to $47 million to AvenCell Therapeutics. Up to $41 million will be provided in exchange for mid-single-digit to low-double-digit royalties on worldwide sales across current and future AvenCell assets, and up…
